Clinical features and natural course of Behçet's disease in 661 cases: A multicentre study

British Journal of Dermatology

Volumn 157, Issue 5, 2007, Pages 901-906

  Alpsoy, E ^a   Donmez, L ^a   Onder, M ^b   Gunasti, S ^c   Usta, A ^d   Karincaoglu, Y ^e   Kandi, B ^f   Buyukkara, S ^a   Keseroglu, O ^b   Uzun, S ^c   Tursen, U ^d   Seyhan, M ^e   Akman, A ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b GAZI UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^c CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

^d MERSIN UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^e INONU UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^f FIRAT UNIVERSITY   (Turkey)

Author keywords

Beh et's disease; Chronology; Mucocutaneous symptoms; Natural course; Onset manifestation

Indexed keywords

ADULT; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; ERYTHEMA NODOSUM; FEMALE; FOLLOW UP; GENITAL ULCER; HUMAN; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PUSTULE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SKIN ALLERGY;

ADULT; AGE OF ONSET; ANALYSIS OF VARIANCE; BEHCET SYNDROME; EYE DISEASES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; JOINT DISEASES; MALE; NERVOUS SYSTEM DISEASES; ORAL ULCER; RETROSPECTIVE STUDIES; SKIN DISEASES; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME; TURKEY; VASCULAR DISEASES;

EID: 35348831914     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08116.x     Document Type: Article

References (16)

1. Yazici H, Tuzun Y, Pazarli H et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 1984 43 : 783 9.
2. Zouboulis CC, Vaiopoulos G, Marcomichelakis N et al. Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behcet's disease in Greece. Clin Exp Rheumatol 2003 21 (4 Suppl. 30 S19 26.
3. Alpsoy E, Donmez L, Bacanli A et al. Review of the clinical manifestations' chronology in 60 patients with Behçet's disease. Dermatology 2003 117 : 354 6.
4. Onder M, Gurer MA. The multiple faces of Behçet's disease and its aetiological factors. J Eur Acad Dermatol Venereol 2001 15 : 126 36.
5. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990 335 : 1078 80.
6. O'Neill TW, Rigby AS, Silman AJ, Barnes C. Validation of the International Study Group criteria for Behçet's disease. Br J Rheumatol 1994 33 : 115 17.
7. Krause I, Mader R, Sulkes J et al. Behçet's disease in Israel: the influence of ethnic origin on disease expression and severity. J Rheumatol 2001 28 : 1033 6.
8. Alpsoy E, Aktekin M, Er H et al. Distribution and frequency of papulopustular lesions in Behçet's disease: a randomized, controlled study. Int J Dermatol 1998 37 : 839 43.
9. Yucel A, Marakli SS, Aksungur VL et al. The effect of the follow-up period of the patients with Behçet's disease on the frequencies of clinical features. J Dermatol 2005 32 : 365 70.
10. Tursen U, Gurler A, Boyvat A. Evaluation of clinical findings according to sex in 2313 Turkish patients with Behçet's disease. Int J Dermatol 2003 42 : 346 51.
11. Kural-Seyahi E, Fresko I, Seyahi N et al. The long-term mortality and morbidity of Behçet syndrome: a 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine (Baltimore) 2003 82 : 60 76.
12. Yazici H, Pazarli H, Barnes CG et al. A controlled trial of azathioprine in Behçet's syndrome. N Engl J Med 1990 322 : 281 5.
13. Assaad-Khalil SH. Low-dose cyclosporin in Behçet's disease: follow-up controlled study with emphasis on extraocular manifestations and neuro-Behçet's disease. In : Behçet's Disease: Basic and Clinical Aspects (O'Duffy JD, Kokmen E, eds). New York : Marcel Dekker, 1991 603 12.
14. Davatchi F, Shahram F, Chams H et al. Pulse cyclophosphamide (PCP) for ocular lesions of Behçet's disease: double blind crossover study. Arthritis Rheum 1999 42 (Suppl. S320.
15. Alpsoy E, Durusoy C, Yilmaz E et al. Interferon alpha-2a in the treatment of Behçet disease: a randomized, placebo-controlled and double blind study. Arch Dermatol 2002 138 : 467 71.
16. Sfikakis PP, Markomichelakis N, Alpsoy E et al. Anti-TNF therapy in the management of Behçet's disease: review and basis for recommendations. Rheumatology (Oxford) 2007 2 : 1 6.